Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1689531
PUBLISHER: GlobalData | PRODUCT CODE: 1689531
United Kingdom Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others
PUBLISHED:
PAGES: 66 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "United Kingdom Neuromodulation Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United Kingdom Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Peripheral Nerve Stimulators (PNS) and Leads
The United Kingdom Neuromodulation Devices Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2023 company share and distribution share data for Neuromodulation Devices Market.
- Global corporate-level profiles of key companies operating within the United Kingdom Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United Kingdom Neuromodulation Devices is segmented as follows -
- Deep Brain Stimulators (DBS)
- Gastric Electric Stimulators (GES)
- Sacral Nerve Stimulators (SNS)
- Spinal Cord Stimulators (SCS)
- Vagus Nerve Stimulators (VNS)
- Peripheral Nerve Stimulators (PNS)
- Leads
Reasons to Buy
The United Kingdom Neuromodulation Devices Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME0813CCDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Neuromodulation Devices Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, United Kingdom
- 3.1 Neuromodulation Devices Market, United Kingdom, Revenue ($m), 2018-2033
- 3.1.1 Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.3 Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.4 Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.1.6 Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
- 3.2 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
- 3.2.1 Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.2 Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.3 Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.4 Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.5 Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.2.6 Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
- 3.3 Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033
- 3.4 Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2023
- 3.5 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United Kingdom, Neuromodulation Devices Market
- 4.1 LivaNova Plc
- 4.1.1 Company Overview
- 4.2 Medtronic Plc
- 4.2.1 Company Overview
- 4.3 Boston Scientific Corp
- 4.3.1 Company Overview
- 4.4 Abbott Laboratories
- 4.4.1 Company Overview
- 4.5 Nevro Corp
- 4.5.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Financial Deals Landscape
- 6.1 Debt Offerings
- 6.1.1 LivaNova Raises USD345 Million in Private Placement of 2.50% Convertible Senior Notes Due 2029
- 6.2 Venture Financing
- 6.2.1 Amber Therapeutics Secures USD100 Million in Series A Venture Financing
- 6.2.2 Neurovalens Raises USD2.65 Million in Venture Financing
- 6.2.3 Phagenesis Secures USD42 Million in Series D Funding
7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 Oct 08, 2024: LivaNova Appoints Susan Podlogar as a New Director
- 7.2 Financial Announcements
- 7.2.1 Oct 30, 2024: LivaNova Announces Q3 2024 Results
- 7.2.2 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
- 7.2.3 Sep 25, 2024: LivaNova to Announce Third-Quarter 2024 Results
- 7.2.4 Apr 05, 2024: RUA Life Sciences : Business Update
8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
Product Code: GDME0813CCDB
List of Table
List of Tables
- Table 1: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 2: Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 3: Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 4: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 5: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 6: Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 7: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Table 8: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
- Table 9: Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), 2018-2033
- Table 10: Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), 2018-2033
- Table 11: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), 2018-2033
- Table 12: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), 2018-2033
- Table 13: Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), 2018-2033
- Table 14: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), 2018-2033
- Table 15: Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033
- Table 16: Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023
- Table 17: Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023
- Table 18: Neuromodulation Devices Market Pipeline Products
- Table 19: LivaNova Raises USD345 Million in Private Placement of 2.50% Convertible Senior Notes Due 2029
- Table 20: Amber Therapeutics Secures USD100 Million in Series A Venture Financing
- Table 21: Neurovalens Raises USD2.65 Million in Venture Financing
- Table 22: Phagenesis Secures USD42 Million in Series D Funding
- Table 23: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figure
List of Figures
- Figure 1: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 5: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 6: Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 7: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
- Figure 8: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
- Figure 9: Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), 2018-2033
- Figure 10: Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), 2018-2033
- Figure 11: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), 2018-2033
- Figure 12: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), 2018-2033
- Figure 13: Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), 2018-2033
- Figure 14: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), 2018-2033
- Figure 15: Neuromodulation Devices Market, United Kingdom, Company Share (%) 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.